tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BMY Stock Latest News

Bristol-Myers Squibb: Balancing Growth and Challenges Amidst Market Dynamics – A Hold Recommendation
RatingsBristol-Myers Squibb: Balancing Growth and Challenges Amidst Market Dynamics – A Hold Recommendation
2h ago
BMY
Bristol-Myers Squibb: Promising Growth Amidst Legacy Challenges and Policy Headwinds
PremiumRatings
Bristol-Myers Squibb: Promising Growth Amidst Legacy Challenges and Policy Headwinds
23h ago
BMY
Bristol Myers announces OS from Phase 3 CheckMate -816 study
PremiumThe Fly
Bristol Myers announces OS from Phase 3 CheckMate -816 study
2d ago
BMY
Bristol Myers announces new five-year results from POETYK PSO trial
PremiumThe Fly
Bristol Myers announces new five-year results from POETYK PSO trial
4d ago
BMY
Bristol-Myers Squibb: Buy Rating Maintained Despite Opdualag Trial Setback, Strong Pipeline Expected to Drive Future Growth
PremiumRatings
Bristol-Myers Squibb: Buy Rating Maintained Despite Opdualag Trial Setback, Strong Pipeline Expected to Drive Future Growth
4d ago
BMY
Bristol Myers reports no new safety signals observed in five-year Sotyktu data
PremiumThe FlyBristol Myers reports no new safety signals observed in five-year Sotyktu data
5d ago
BMY
Bristol Myers’ Phase 3 RELATIVITY-098 for Opdualag did not meet primary endpoint
Premium
The Fly
Bristol Myers’ Phase 3 RELATIVITY-098 for Opdualag did not meet primary endpoint
8d ago
BMY
Cytokinetics upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Cytokinetics upgraded to Overweight from Equal Weight at Morgan Stanley
8d ago
BMY
CYTK
Trump Is Expected to Support Medicare Drug Price Negotiations
PremiumMarket News
Trump Is Expected to Support Medicare Drug Price Negotiations
10d ago
BMY
LLY
Bristol Myers announces results from Phase 2 TRANSCEND FL trial
PremiumThe Fly
Bristol Myers announces results from Phase 2 TRANSCEND FL trial
11d ago
BMY
Trump Trade: President advocates to close carried interest tax loophole
PremiumThe Fly
Trump Trade: President advocates to close carried interest tax loophole
14d ago
X
BX
Bristol Myers price target raised to $62 from $60 at Wells Fargo
PremiumThe Fly
Bristol Myers price target raised to $62 from $60 at Wells Fargo
14d ago
BMY
Bristol-Myers Squibb: Hold Rating Amid Mixed Projections and Potential Catalysts
PremiumRatingsBristol-Myers Squibb: Hold Rating Amid Mixed Projections and Potential Catalysts
14d ago
BMY
Cytokinetics initiated with a Buy at Citi
Premium
The Fly
Cytokinetics initiated with a Buy at Citi
14d ago
BMY
CYTK
Bristol-Myers Squibb: Hold Rating Amid Restructuring and Revenue Challenges
Premium
Ratings
Bristol-Myers Squibb: Hold Rating Amid Restructuring and Revenue Challenges
14d ago
BMY
Bristol Myers Squibb Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Bristol Myers Squibb Reports Strong 2024 Financial Growth
14d ago
BMY
Bristol-Myers Squibb: Positive Earnings Call Highlights
PremiumCompany Announcements
Bristol-Myers Squibb: Positive Earnings Call Highlights
15d ago
BMY
White House readying order to fire thousands of federal health workers, WSJ says
PremiumThe Fly
White House readying order to fire thousands of federal health workers, WSJ says
15d ago
CI
AZN
Camzyos news has negative readthroughs for Cytokinetics, says BofA
PremiumThe Fly
Camzyos news has negative readthroughs for Cytokinetics, says BofA
15d ago
BMY
CYTK
Qualcomm, Eli Lilly report quarterly earnings beats: Morning Buzz
PremiumThe FlyQualcomm, Eli Lilly report quarterly earnings beats: Morning Buzz
15d ago
C
F
Cytokinetics share weakness on updated Camzyos REMS overdone, says Truist
Premium
The Fly
Cytokinetics share weakness on updated Camzyos REMS overdone, says Truist
15d ago
BMY
CYTK
Morning Movers: Roblox sinks following fourth quarter results and guidance
Premium
The Fly
Morning Movers: Roblox sinks following fourth quarter results and guidance
15d ago
F
PM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >